{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:19:19Z","timestamp":1784614759492,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M743233"],"award-info":[{"award-number":["2023M743233"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the medical science and technology program of henan province"},{"DOI":"10.13039\/501100007128","name":"Shaanxi Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2022JQ-815"],"award-info":[{"award-number":["2022JQ-815"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["252102311230"],"award-info":[{"award-number":["252102311230"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and technology project of henan province"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82020108030"],"award-info":[{"award-number":["82020108030"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U21A20416"],"award-info":[{"award-number":["U21A20416"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.intimp.2025.115076","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T16:43:10Z","timestamp":1749919390000},"page":"115076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The novel HDAC6 inhibitor 9r induces anti-tumor responses by enhancing T cell response and inducing MHC class II signaling pathways in esophageal cancer"],"prefix":"10.1016","volume":"161","author":[{"given":"Hui-Qin","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Qian","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Xian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Yi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2025.115076_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.intimp.2025.115076_bb0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2188\/jea.JE20120162","article-title":"Epidemiology of esophageal cancer in Japan and China","volume":"23","author":"Lin","year":"2013","journal-title":"J. Epidemiol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115076_bb0015","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.bjc.6605246","article-title":"Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005","volume":"101","author":"Cook","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.intimp.2025.115076_bb0020","article-title":"The angiogenic genes predict prognosis and immune characteristics in esophageal squamous cell carcinoma: evidence from multi-omics and experimental verification","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115076_bb0025","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.intimp.2025.115076_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123219","article-title":"Curriculum vitae of HDAC6 in solid tumors","volume":"230","author":"Zheng","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115076_bb0035","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/s41419-022-05335-1","article-title":"HDAC6-dependent deacetylation of TAK1 enhances sIL-6R release to promote macrophage M2 polarization in colon cancer","volume":"13","author":"Xu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.intimp.2025.115076_bb0040","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1038\/s41388-021-01655-2","article-title":"Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor","volume":"40","author":"Ge","year":"2021","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.intimp.2025.115076_bb0045","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/s41416-023-02195-0","article-title":"Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling","volume":"128","author":"Tsai","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2025.115076_bb0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13578-023-00987-8","article-title":"RBX1 regulates PKM alternative splicing to facilitate anaplastic thyroid carcinoma metastasis and aerobic glycolysis by destroying the SMAR1\/HDAC6 complex","volume":"13","author":"Xu","year":"2023","journal-title":"Cell Biosci."},{"issue":"28","key":"10.1016\/j.intimp.2025.115076_bb0055","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1038\/sj.onc.1208646","article-title":"Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer","volume":"24","author":"Saji","year":"2005","journal-title":"Oncogene"},{"issue":"45","key":"10.1016\/j.intimp.2025.115076_bb0060","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.1038\/s41388-018-0379-9","article-title":"Histone deacetylase 6 regulates the immunosuppressive properties of cancer-associated fibroblasts in breast cancer through the STAT3-COX2-dependent pathway","volume":"37","author":"Li","year":"2018","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.intimp.2025.115076_bb0065","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1038\/s41598-020-60409-4","article-title":"Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer","volume":"10","author":"Moufarrij","year":"2020","journal-title":"Sci. Rep."},{"issue":"6510","key":"10.1016\/j.intimp.2025.115076_bb0070","doi-asserted-by":"crossref","DOI":"10.1126\/science.aas8995","article-title":"HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation","volume":"369","author":"Magupalli","year":"2020","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.intimp.2025.115076_bb0075","first-page":"1622","article-title":"Phase separation of phospho-HDAC6 drives aberrant chromatin architecture in triple-negative breast cancer","volume":"5","author":"Lu","year":"2024","journal-title":"Nat. Can."},{"issue":"13","key":"10.1016\/j.intimp.2025.115076_bb0080","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1158\/1078-0432.CCR-16-2526","article-title":"Ricolinostat, the First Selective Histone Deacetylase 6 Inhibitor, in Combination with Bortezomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma","volume":"23","author":"Vogl","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.intimp.2025.115076_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70158","article-title":"Rational Design, Synthesis, and Biological Assessment of Potential Indole-Capped HDAC6 Inhibitors for Gastric Cancer Suppression","volume":"6","author":"Gao","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.intimp.2025.115076_bb0090","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.2147\/CMAR.S178575","article-title":"Histone deacetylase 6 expression in metastatic lymph nodes is a valuable prognostic marker for resected node-positive esophageal squamous cell cancer","volume":"10","author":"Xie","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.intimp.2025.115076_bb0095","article-title":"Structural optimization of 1,3-Diaryl-1,2,4-triazole-capped histone deacetylase 6 inhibitors to obtain novel Antiesophageal Cancer candidates","author":"Zhang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2025.115076_bb0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.lungcan.2017.07.030","article-title":"MHC class II expression in lung cancer","volume":"112","author":"He","year":"2017","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2025.115076_bb0105","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0092-8674(00)81025-9","article-title":"Invariant chain structure and MHC class II function","volume":"84","author":"Cresswell","year":"1996","journal-title":"Cell"},{"issue":"Suppl","key":"10.1016\/j.intimp.2025.115076_bb0110","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0092-8674(02)00696-7","article-title":"Genetic control of MHC class II expression","volume":"109","author":"Ting","year":"2002","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.intimp.2025.115076_bb0115","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nri3754","article-title":"Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?","volume":"14","author":"Kambayashi","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115076_bb0120","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1158\/1078-0432.CCR-15-1125","article-title":"RAS\/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast Cancer: therapeutic cooperation between MEK and PD-1\/PD-L1 immune checkpoint inhibitors","volume":"22","author":"Loi","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.intimp.2025.115076_bb0125","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/ijc.25106","article-title":"Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genes","volume":"127","author":"Michel","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"23","key":"10.1016\/j.intimp.2025.115076_bb0130","doi-asserted-by":"crossref","first-page":"7667","DOI":"10.1158\/1078-0432.CCR-08-0479","article-title":"Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer","volume":"14","author":"Callahan","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2025.115076_bb0135","doi-asserted-by":"crossref","first-page":"10582","DOI":"10.1038\/ncomms10582","article-title":"Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1\/PD-L1 therapy","volume":"7","author":"Johnson","year":"2016","journal-title":"Nat. Commun."},{"issue":"450","key":"10.1016\/j.intimp.2025.115076_bb0140","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar3342","article-title":"MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma","volume":"10","author":"Rodig","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2025.115076_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113392","article-title":"Identification of novel 1,3-diaryl-1,2,4-triazole-capped histone deacetylase 6 inhibitors with potential anti-gastric cancer activity","volume":"218","author":"Zhang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.intimp.2025.115076_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112970","article-title":"Design, synthesis and biological evaluation of novel thiosemicarbazone-indole derivatives targeting prostate cancer cells","volume":"210","author":"He","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2025.115076_bb0155","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1021\/acs.jmedchem.8b01090","article-title":"Synthesis and biological investigation of phenothiazine-based Benzhydroxamic acids as selective histone deacetylase 6 inhibitors","volume":"62","author":"Vogerl","year":"2019","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2025.115076_bb0160","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3233\/CBM-160298","article-title":"HDAC6 serves as a biomarker for the prognosis of patients with renal cell carcinoma","volume":"19","author":"Zhang","year":"2017","journal-title":"Cancer Biomark."},{"issue":"20","key":"10.1016\/j.intimp.2025.115076_bb0165","doi-asserted-by":"crossref","first-page":"6962","DOI":"10.1158\/1078-0432.CCR-04-0455","article-title":"HDAC6 expression is correlated with better survival in breast cancer","volume":"10","author":"Zhang","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.intimp.2025.115076_bb0170","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41419-018-0788-2","article-title":"Ricolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d\/PI3K\/AKT\/mTOR and ERK pathways","volume":"9","author":"Cao","year":"2018","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.intimp.2025.115076_bb0175","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"issue":"8","key":"10.1016\/j.intimp.2025.115076_bb0180","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1002\/jcb.26841","article-title":"Silence of HDAC6 suppressed esophageal squamous cell carcinoma proliferation and migration by disrupting chaperone function of HSP90","volume":"119","author":"Tao","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.intimp.2025.115076_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105992","article-title":"SAR study culminates in a series of HDAC6 selective inhibitors featuring Schisandrin C-analogous cap as potential immunomodulatory agents for cancer therapy","volume":"127","author":"Tao","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.intimp.2025.115076_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.590072","article-title":"HDAC6 inhibition alleviates CLL-induced T-cell dysfunction and enhances immune checkpoint blockade efficacy in the emu-TCL1 model","volume":"11","author":"Maharaj","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115076_bb0195","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/eji.200424964","article-title":"Mini-review: specificity and expression of CIITA, the master regulator of MHC class II genes","volume":"34","author":"LeibundGut-Landmann","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2025.115076_bb0200","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-065X.1982.tb00434.x","article-title":"Antigen presentation by vascular endothelial cells and epidermal Langerhans cells: the role of HLA-DR","volume":"66","author":"Hirschberg","year":"1982","journal-title":"Immunol. Rev."},{"issue":"7","key":"10.1016\/j.intimp.2025.115076_bb0205","first-page":"421","article-title":"HLA-DQ distribution and risk assessment of celiac disease in a Spanish center","volume":"110","author":"Martinez-Ojinaga","year":"2018","journal-title":"Rev. Esp. Enferm. Dig."},{"issue":"5","key":"10.1016\/j.intimp.2025.115076_bb0210","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.161.5.1135","article-title":"Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer","volume":"161","author":"Doyle","year":"1985","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.intimp.2025.115076_bb0215","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/FPC.0000000000000461","article-title":"Identification of potential druggable targets of cell cycle with small-molecule inhibitors in oral squamous cell carcinoma","volume":"32","author":"Zhou","year":"2022","journal-title":"Pharmacogenet. Genomics"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925010665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925010665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T19:49:14Z","timestamp":1775764154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925010665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":43,"alternative-id":["S1567576925010665"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115076","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The novel HDAC6 inhibitor 9r induces anti-tumor responses by enhancing T cell response and inducing MHC class II signaling pathways in esophageal cancer","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115076"}}